Estar Medical manufactures and markets its proprietary products worldwide since its establishment in 1992. The Estar Medical team offers a unique blend of scientific, engineering and management experts that constantly strive to improve the performance of Estar's products and services. Estar is always focused on exceeding customer expectations by improving key processes and implementing flexible and adaptive response to customer's needs.
Estar’s certified Quality System is in full compliance with ISO 13485 and ISO 9001 international standards. The safety and effectiveness of our products have been repeatedly proven in a number of clinical studies (link to "Articles" under "News & Events").
The products are approved for use in EU (CE marked) and in other countries worldwide.
Tropocells system is cleared by the US FDA (510k) for the following intended use:
"Safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care. The PRP is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics."